Related Experiment Video
Updated: Jul 16, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
The impact of Helicobacter pylori infection on Pregnancy: A narrative review
Marc Besnier1, Jean-Yves Joseph1, Alice Laurandeau1
1Université de Poitiers, Département de Médecine Générale, Poitiers, France.
Background:
Helicobacter pylori infection has systemic inflammatory, metabolic, and endothelial effects beyond the digestive tract. During pregnancy, these mechanisms may contribute to several maternal complications. This review aimed to summarize the extra-digestive impact of H. pylori infection in pregnant women.
Methods:
A narrative review of the literature was conducted using PubMed and the Cochrane Library. Nineteen studies published up to August 2025 were included.
Results:
Three major pregnancy complications were consistently associated with H. pylori infection. First, iron-deficiency anaemia may be aggravated through impaired iron absorption, chronic inflammation, and reduced response to oral supplementation. Second, systemic inflammation and insulin signalling alterations, particularly with virulent strains, may enhance physiological insulin resistance and increase the risk of gestational diabetes mellitus. Third, endothelial dysfunction, oxidative stress, and angiogenic imbalance may contribute to abnormal placentation and preeclampsia. Several studies also reported adverse neonatal outcomes, including lower birth weight and prematurity.
Conclusion:
Current evidence suggests that H. pylori infection may contribute to iron-deficiency anaemia, gestational diabetes mellitus, and preeclampsia through interconnected inflammatory and vascular mechanisms. Although causality remains uncertain, targeted screening and individualized monitoring strategies could be considered in selected high-risk pregnant women.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
